Hemay007

DRUG2 trials

Sponsors

Hemay Pharmaceutical PTY. LTD., Tianjin Hemay Pharmaceutical Co., Ltd

Conditions

Inflammatory Bowel DiseaseUlcerative Colitis

Phase 1

PhaseⅠFirst-in-Human Study of Hemay007 in Healthy Volunteers

Hemay Pharmaceutical PTY. LTD.Inflammatory Bowel Disease

Start: 2017-01-09End: 2018-03-31Target: 82Updated: 2017-10-24

Phase 2

Phase II Study of Hemay007 in Patients With Active Ulcerative Colitis

TerminatedNCT03977480

Tianjin Hemay Pharmaceutical Co., LtdUlcerative Colitis

Start: 2019-08-13End: 2022-08-12Updated: 2024-03-01